| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 7.50e-10 | 8 | 136 | 5 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 7.50e-10 | 8 | 136 | 5 | GO:0034875 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 6.09e-09 | 11 | 136 | 5 | GO:0101020 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.59e-08 | 14 | 136 | 5 | GO:0008401 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 3.87e-08 | 15 | 136 | 5 | GO:0016725 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 1.23e-06 | 4 | 136 | 3 | GO:0008390 | |
| GeneOntologyMolecularFunction | methyl-CpG binding | 2.01e-06 | 31 | 136 | 5 | GO:0008327 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 3.06e-06 | 5 | 136 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 3.06e-06 | 5 | 136 | 3 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 3.06e-06 | 5 | 136 | 3 | GO:0062181 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 3.23e-06 | 34 | 136 | 5 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 3.75e-06 | 35 | 136 | 5 | GO:0070330 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 6.09e-06 | 6 | 136 | 3 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 6.09e-06 | 6 | 136 | 3 | GO:0070576 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 6.09e-06 | 6 | 136 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 6.09e-06 | 6 | 136 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 1.06e-05 | 7 | 136 | 3 | GO:0070643 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 1.69e-05 | 8 | 136 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 2.04e-05 | 49 | 136 | 5 | GO:0016712 | |
| GeneOntologyMolecularFunction | metallodipeptidase activity | 3.58e-05 | 10 | 136 | 3 | GO:0070573 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 4.60e-05 | 2 | 136 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 4.60e-05 | 2 | 136 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 4.60e-05 | 2 | 136 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 4.60e-05 | 2 | 136 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | cadherin binding | PUF60 LARP1 CC2D1A NIBAN2 DCHS1 KDR HSPA1A HCFC1 HSPA8 NOTCH3 | 1.12e-04 | 339 | 136 | 10 | GO:0045296 |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 1.32e-04 | 15 | 136 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | denatured protein binding | 1.38e-04 | 3 | 136 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | dipeptidase activity | 2.34e-04 | 18 | 136 | 3 | GO:0016805 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 2.74e-04 | 4 | 136 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 2.74e-04 | 4 | 136 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 4.54e-04 | 5 | 136 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 4.54e-04 | 5 | 136 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 4.54e-04 | 5 | 136 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 4.54e-04 | 5 | 136 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.15e-03 | 115 | 136 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | oxygen binding | 2.03e-03 | 37 | 136 | 3 | GO:0019825 | |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 2.43e-03 | 11 | 136 | 2 | GO:0019870 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 2.54e-03 | 40 | 136 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PUF60 LARP1 CC2D1A NIBAN2 KIRREL3 DCHS1 KDR HSPA1A HCFC1 HSPA8 NOTCH3 | 2.67e-03 | 599 | 136 | 11 | GO:0050839 |
| GeneOntologyMolecularFunction | type II transforming growth factor beta receptor binding | 2.91e-03 | 12 | 136 | 2 | GO:0005114 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 2.92e-03 | 42 | 136 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | demethylase activity | 3.34e-03 | 44 | 136 | 3 | GO:0032451 | |
| GeneOntologyMolecularFunction | heme binding | 4.10e-03 | 154 | 136 | 5 | GO:0020037 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 4.53e-03 | 49 | 136 | 3 | GO:0004180 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 8.10e-07 | 12 | 134 | 4 | GO:0070989 | |
| GeneOntologyBiologicalProcess | alkaloid catabolic process | 2.66e-06 | 5 | 134 | 3 | GO:0009822 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 3.96e-06 | 37 | 134 | 5 | GO:0042178 | |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 5.29e-06 | 6 | 134 | 3 | GO:0016098 | |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 9.51e-06 | 44 | 134 | 5 | GO:0006346 | |
| GeneOntologyBiologicalProcess | demethylation | 1.64e-05 | 24 | 134 | 4 | GO:0070988 | |
| GeneOntologyBiologicalProcess | alkaloid metabolic process | 2.19e-05 | 9 | 134 | 3 | GO:0009820 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 2.19e-05 | 9 | 134 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 2.88e-05 | 55 | 134 | 5 | GO:0140718 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | MBD3L5 MBD3L2 PATZ1 CC2D1A MBD3L3 MBD3L4 PRDM2 MBD3L2B TGFB1 MSX2 ZNF469 TLE4 INSM2 SLA2 ZFHX3 HSPA1A HCFC1 NOTCH3 | 1.62e-04 | 1053 | 134 | 18 | GO:0000122 |
| GeneOntologyCellularComponent | inhibin-betaglycan-ActRII complex | 1.29e-04 | 3 | 138 | 2 | GO:0034673 | |
| Domain | MeCpG-bd_2/3_C_dom | 8.21e-08 | 7 | 132 | 4 | IPR025884 | |
| Domain | MBD2/MBD3_p55-bd | 8.21e-08 | 7 | 132 | 4 | IPR032343 | |
| Domain | MBDa | 8.21e-08 | 7 | 132 | 4 | PF16564 | |
| Domain | MBD_C | 8.21e-08 | 7 | 132 | 4 | PF14048 | |
| Domain | Cyt_P450_E_grp-II | 3.42e-06 | 5 | 132 | 3 | IPR002402 | |
| Domain | Cyt_P450_E_CYP3A | 6.80e-06 | 6 | 132 | 3 | IPR008072 | |
| Domain | Cyt_P450_CS | 3.57e-05 | 53 | 132 | 5 | IPR017972 | |
| Domain | CNDP/DUG1 | 4.96e-05 | 2 | 132 | 2 | IPR017153 | |
| Domain | CYTOCHROME_P450 | 5.10e-05 | 57 | 132 | 5 | PS00086 | |
| Domain | - | 5.55e-05 | 58 | 132 | 5 | 1.10.630.10 | |
| Domain | p450 | 5.55e-05 | 58 | 132 | 5 | PF00067 | |
| Domain | Cyt_P450 | 6.54e-05 | 60 | 132 | 5 | IPR001128 | |
| Domain | ARGE_DAPE_CPG2_1 | 1.48e-04 | 3 | 132 | 2 | PS00758 | |
| Domain | ARGE_DAPE_CPG2_2 | 1.48e-04 | 3 | 132 | 2 | PS00759 | |
| Domain | ArgE/DapE_CS | 1.48e-04 | 3 | 132 | 2 | IPR001261 | |
| Domain | HSP70 | 1.81e-04 | 16 | 132 | 3 | PF00012 | |
| Domain | HSP70_2 | 2.18e-04 | 17 | 132 | 3 | PS00329 | |
| Domain | HSP70_1 | 2.18e-04 | 17 | 132 | 3 | PS00297 | |
| Domain | HSP70_3 | 2.18e-04 | 17 | 132 | 3 | PS01036 | |
| Domain | Hsp_70_fam | 2.61e-04 | 18 | 132 | 3 | IPR013126 | |
| Domain | Cyt_P450_E_grp-I | 2.84e-04 | 45 | 132 | 4 | IPR002401 | |
| Domain | VWFA | 2.88e-04 | 82 | 132 | 5 | PS50234 | |
| Domain | VWA | 3.23e-04 | 84 | 132 | 5 | SM00327 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF142 ZNF843 SALL3 PATZ1 ADNP2 ZNF831 PRDM2 ZNF469 MTF1 SP6 INSM2 ZFHX3 ZC3H7B ZBTB3 ZNF687 | 3.84e-04 | 775 | 132 | 15 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF142 ZNF843 SALL3 PATZ1 ADNP2 ZNF831 PRDM2 ZNF469 MTF1 SP6 INSM2 ZFHX3 ZC3H7B ZBTB3 ZNF687 | 3.95e-04 | 777 | 132 | 15 | PS00028 |
| Domain | - | 4.89e-04 | 5 | 132 | 2 | 3.30.70.360 | |
| Domain | M20_dimer | 4.89e-04 | 5 | 132 | 2 | PF07687 | |
| Domain | Peptidase_M20_dimer | 4.89e-04 | 5 | 132 | 2 | IPR011650 | |
| Domain | Peptidase_M20 | 4.89e-04 | 5 | 132 | 2 | PF01546 | |
| Domain | Peptidase_M20 | 4.89e-04 | 5 | 132 | 2 | IPR002933 | |
| Domain | Znf_C2H2-like | ZNF142 ZNF843 SALL3 PATZ1 ADNP2 ZNF831 PRDM2 ZNF469 MTF1 SP6 INSM2 ZFHX3 ZC3H7B ZBTB3 ZNF687 | 5.08e-04 | 796 | 132 | 15 | IPR015880 |
| Domain | Znf_C2H2 | ZNF142 ZNF843 SALL3 PATZ1 ADNP2 ZNF831 PRDM2 ZNF469 MTF1 SP6 INSM2 ZFHX3 ZC3H7B ZBTB3 ZNF687 | 5.70e-04 | 805 | 132 | 15 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF142 ZNF843 SALL3 PATZ1 ADNP2 ZNF831 PRDM2 ZNF469 MTF1 SP6 INSM2 ZFHX3 ZC3H7B ZBTB3 ZNF687 | 5.93e-04 | 808 | 132 | 15 | SM00355 |
| Domain | VWA | 6.59e-04 | 56 | 132 | 4 | PF00092 | |
| Domain | VWF_A | 6.87e-04 | 99 | 132 | 5 | IPR002035 | |
| Domain | AT_hook | 8.91e-04 | 27 | 132 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 8.91e-04 | 27 | 132 | 3 | IPR017956 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF142 ZNF843 SALL3 PATZ1 ZNF831 PRDM2 ZNF469 MTF1 SP6 INSM2 ZFHX3 ZBTB3 ZNF687 | 1.28e-03 | 694 | 132 | 13 | IPR013087 |
| Pathway | REACTOME_XENOBIOTICS | 2.60e-07 | 23 | 88 | 5 | M5372 | |
| Pathway | REACTOME_XENOBIOTICS | 4.07e-07 | 25 | 88 | 5 | MM14846 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 6.75e-07 | 12 | 88 | 4 | MM15616 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 8.92e-07 | 29 | 88 | 5 | M2920 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 7.82e-06 | 21 | 88 | 4 | M39631 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 9.52e-06 | 22 | 88 | 4 | MM15614 | |
| Pathway | BIOCARTA_ACETAMINOPHEN_PATHWAY | 1.29e-05 | 8 | 88 | 3 | MM1547 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 1.37e-05 | 24 | 88 | 4 | M46445 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 3.92e-05 | 31 | 88 | 4 | M39476 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 4.13e-05 | 62 | 88 | 5 | M39653 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 4.46e-05 | 32 | 88 | 4 | M39567 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 4.82e-05 | 64 | 88 | 5 | M5650 | |
| Pathway | KEGG_RETINOL_METABOLISM | 4.82e-05 | 64 | 88 | 5 | M9488 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 4.97e-05 | 12 | 88 | 3 | M48064 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 5.60e-05 | 66 | 88 | 5 | MM14839 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 6.43e-05 | 13 | 88 | 3 | MM14952 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 7.43e-05 | 70 | 88 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 8.51e-05 | 72 | 88 | 5 | M9257 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.01e-04 | 15 | 88 | 3 | MM15697 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | CYP2C19 CYP2C9 CYP3A4 CYP3A5 IL17B TGFB1 TGFBR3 HSPA1A SLC39A5 | 1.47e-04 | 314 | 88 | 9 | M39428 |
| Pathway | REACTOME_ASPIRIN_ADME | 1.74e-04 | 45 | 88 | 4 | MM15694 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.79e-04 | 18 | 88 | 3 | MM14843 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 2.88e-04 | 21 | 88 | 3 | MM17231 | |
| Pathway | REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA | 3.79e-04 | 55 | 88 | 4 | MM15137 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.80e-04 | 23 | 88 | 3 | MM16639 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 3.80e-04 | 23 | 88 | 3 | MM14953 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 4.78e-04 | 104 | 88 | 5 | M738 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 4.97e-04 | 59 | 88 | 4 | M39886 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 5.00e-04 | 105 | 88 | 5 | MM14842 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 5.51e-04 | 26 | 88 | 3 | MM15190 | |
| Pathway | REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION | 5.69e-04 | 6 | 88 | 2 | MM15534 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 5.69e-04 | 6 | 88 | 2 | M27909 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 6.88e-04 | 28 | 88 | 3 | M27254 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 7.64e-04 | 29 | 88 | 3 | M39676 | |
| Pathway | REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION | 7.93e-04 | 7 | 88 | 2 | M27807 | |
| Pathway | REACTOME_DRUG_ADME | 8.83e-04 | 119 | 88 | 5 | MM15692 | |
| Pathway | REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING | 1.00e-03 | 71 | 88 | 4 | MM14787 | |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 1.05e-03 | 185 | 88 | 6 | M39718 | |
| Pathway | REACTOME_TGFBR3_REGULATES_TGF_BETA_SIGNALING | 1.05e-03 | 8 | 88 | 2 | M48252 | |
| Pathway | REACTOME_TGFBR3_REGULATES_TGF_BETA_SIGNALING | 1.05e-03 | 8 | 88 | 2 | MM17233 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 1.05e-03 | 8 | 88 | 2 | M27135 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.05e-03 | 8 | 88 | 2 | M27891 | |
| Pathway | REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING | 1.06e-03 | 72 | 88 | 4 | M539 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.11e-03 | 73 | 88 | 4 | MM14948 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 1.12e-03 | 33 | 88 | 3 | MM1448 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.35e-03 | 9 | 88 | 2 | M27143 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.57e-03 | 37 | 88 | 3 | M39506 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.69e-03 | 38 | 88 | 3 | M27255 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.71e-03 | 82 | 88 | 4 | M27250 | |
| Pathway | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | 2.04e-03 | 86 | 88 | 4 | MM15140 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 2.04e-03 | 11 | 88 | 2 | M27130 | |
| Pathway | WP_ALANINE_AND_ASPARTATE_METABOLISM | 2.44e-03 | 12 | 88 | 2 | M39331 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 2.44e-03 | 12 | 88 | 2 | M39611 | |
| Pathway | WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS | 2.44e-03 | 12 | 88 | 2 | M39842 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.47e-03 | 219 | 88 | 6 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.52e-03 | 220 | 88 | 6 | M10320 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.59e-03 | 44 | 88 | 3 | M45014 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.61e-03 | 92 | 88 | 4 | MM14951 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GBF1 PCNX3 SZT2 VWA8 PUF60 GTSE1 CC2D1A IRF5 SRCAP MBD6 WNK1 ADGRA2 DENND1A TFE3 PRR12 MSX2 SCAF1 IGF2R KCNK5 RIC8A ZC3H7B HCFC1 TRAPPC9 ABCC10 RAI1 TBCD ZNF687 | 5.68e-14 | 1105 | 141 | 27 | 35748872 |
| Pubmed | 1.02e-12 | 5 | 141 | 5 | 18156313 | ||
| Pubmed | 6.10e-12 | 6 | 141 | 5 | 12504854 | ||
| Pubmed | Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol. | 6.10e-12 | 6 | 141 | 5 | 8043019 | |
| Pubmed | 6.10e-12 | 6 | 141 | 5 | 18942147 | ||
| Pubmed | Identification and characterization of human FNBP3 gene in silico. | 5.66e-11 | 8 | 141 | 5 | 12964049 | |
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 18021343 | ||
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 19337788 | ||
| Pubmed | CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. | 1.29e-09 | 5 | 141 | 4 | 20833683 | |
| Pubmed | GTSE1 LARP1 CC2D1A TACC2 NIBAN2 WNK1 GORASP2 FAM83G HSPA1A HSPA1B HCFC1 TP53BP1 MRTFA ZNF687 RAVER1 | 2.38e-09 | 503 | 141 | 15 | 16964243 | |
| Pubmed | 2.96e-09 | 15 | 141 | 5 | 15701600 | ||
| Pubmed | 3.86e-09 | 6 | 141 | 4 | 17900275 | ||
| Pubmed | 3.86e-09 | 6 | 141 | 4 | 19934793 | ||
| Pubmed | 6.07e-09 | 17 | 141 | 5 | 27197076 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 1.51e-08 | 20 | 141 | 5 | 9890157 | |
| Pubmed | 1.79e-08 | 8 | 141 | 4 | 20147896 | ||
| Pubmed | 3.21e-08 | 9 | 141 | 4 | 19350405 | ||
| Pubmed | 3.21e-08 | 9 | 141 | 4 | 17178267 | ||
| Pubmed | 3.21e-08 | 9 | 141 | 4 | 18496131 | ||
| Pubmed | Perioperative genomic profiles using structure-specific oligonucleotide probes. | 3.24e-08 | 23 | 141 | 5 | 19474452 | |
| Pubmed | 5.33e-08 | 10 | 141 | 4 | 20235787 | ||
| Pubmed | 5.33e-08 | 10 | 141 | 4 | 18240903 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 23846873 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 11726664 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 23352621 | ||
| Pubmed | High fat diet induced obesity is mitigated in Cyp3a-null female mice. | 6.52e-08 | 3 | 141 | 3 | 29738703 | |
| Pubmed | A novel female-specific member of the CYP3A gene subfamily in the mouse liver. | 6.52e-08 | 3 | 141 | 3 | 10775455 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 19226368 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 16621788 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 37258238 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 28567424 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 25005602 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 23469989 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 21081028 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 9143324 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 37584614 | ||
| Pubmed | CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism. | 6.52e-08 | 3 | 141 | 3 | 21148252 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 23370405 | ||
| Pubmed | The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors. | 6.52e-08 | 3 | 141 | 3 | 21692828 | |
| Pubmed | Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism. | 6.52e-08 | 3 | 141 | 3 | 26212543 | |
| Pubmed | Association of genetic polymorphisms with warfarin dose requirements in Chinese patients. | 6.52e-08 | 3 | 141 | 3 | 23941071 | |
| Pubmed | Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms. | 6.52e-08 | 3 | 141 | 3 | 17827141 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 12147261 | ||
| Pubmed | Mouse liver cytochrome P-450 (P-450IIIAM1): its cDNA cloning and inducibility by dexamethasone. | 6.52e-08 | 3 | 141 | 3 | 1339292 | |
| Pubmed | Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. | 6.52e-08 | 3 | 141 | 3 | 12617959 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 31128914 | ||
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 6.52e-08 | 3 | 141 | 3 | 15129916 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 19188337 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 18394438 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 11284050 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 14733933 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 35081606 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 28025138 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 22291988 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 15548719 | ||
| Pubmed | Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol. | 6.52e-08 | 3 | 141 | 3 | 2402224 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 7932176 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 37326083 | ||
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 8.36e-08 | 11 | 141 | 4 | 15469410 | |
| Pubmed | 8.36e-08 | 11 | 141 | 4 | 15039299 | ||
| Pubmed | 1.34e-07 | 30 | 141 | 5 | 20529763 | ||
| Pubmed | 1.80e-07 | 13 | 141 | 4 | 19696793 | ||
| Pubmed | 1.80e-07 | 13 | 141 | 4 | 16771603 | ||
| Pubmed | Influence of ethnicity on pharmacogenetic variation in the Ghanaian population. | 1.80e-07 | 13 | 141 | 4 | 19546880 | |
| Pubmed | 2.51e-07 | 14 | 141 | 4 | 20970553 | ||
| Pubmed | A novel form of mouse cytochrome P450 3A (Cyp3a-16). Its cDNA cloning and expression in fetal liver. | 2.60e-07 | 4 | 141 | 3 | 7813478 | |
| Pubmed | Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. | 2.60e-07 | 4 | 141 | 3 | 17975676 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 16924387 | ||
| Pubmed | Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans. | 2.60e-07 | 4 | 141 | 3 | 27638959 | |
| Pubmed | Knockout of mouse Cyp3a gene enhances synthesis of cholesterol and bile acid in the liver. | 2.60e-07 | 4 | 141 | 3 | 23709690 | |
| Pubmed | Thalidomide-induced limb abnormalities in a humanized CYP3A mouse model. | 2.60e-07 | 4 | 141 | 3 | 26903378 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 32130917 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 15248218 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 17936928 | ||
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 2.60e-07 | 4 | 141 | 3 | 18299791 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 17635181 | ||
| Pubmed | Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients. | 2.60e-07 | 4 | 141 | 3 | 17922881 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 10230766 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 18379898 | ||
| Pubmed | Mouse aortic muscle cells respond to oxygen following cytochrome P450 3A13 gene transfer. | 2.60e-07 | 4 | 141 | 3 | 23656416 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 14509827 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 23125282 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 21088200 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 36050438 | ||
| Pubmed | Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice. | 2.60e-07 | 4 | 141 | 3 | 31633069 | |
| Pubmed | Humanized xenobiotic response in mice expressing nuclear receptor SXR. | 2.60e-07 | 4 | 141 | 3 | 10935643 | |
| Pubmed | Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors. | 2.60e-07 | 4 | 141 | 3 | 12958193 | |
| Pubmed | Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians. | 2.60e-07 | 4 | 141 | 3 | 24443221 | |
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 2.60e-07 | 4 | 141 | 3 | 22956628 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 32279544 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 25319358 | ||
| Pubmed | The transcription factor E4bp4 regulates the expression and activity of Cyp3a11 in mice. | 2.60e-07 | 4 | 141 | 3 | 30796914 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 7803471 | ||
| Pubmed | Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone. | 5.30e-07 | 117 | 141 | 7 | 18996102 | |
| Pubmed | 5.91e-07 | 17 | 141 | 4 | 19424794 | ||
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 6.48e-07 | 5 | 141 | 3 | 11266076 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 19920203 | ||
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 23090875 | ||
| Pubmed | Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19. | 6.48e-07 | 5 | 141 | 3 | 16116487 | |
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 6.48e-07 | 5 | 141 | 3 | 11584023 | |
| Interaction | TOP3B interactions | GBF1 PCNX3 SZT2 VWA8 PUF60 GTSE1 CC2D1A IRF5 SRCAP MBD6 WNK1 ADGRA2 DENND1A TFE3 PRR12 MSX2 SCAF1 GORASP2 IGF2R KCNK5 RIC8A ZC3H7B HCFC1 TRAPPC9 ABCC10 TP53BP1 RAI1 TBCD ZNF687 | 1.31e-07 | 1470 | 136 | 29 | int:TOP3B |
| Interaction | CYP3A4 interactions | 4.41e-06 | 17 | 136 | 4 | int:CYP3A4 | |
| Cytoband | 19p13.2 | 6.07e-07 | 229 | 141 | 8 | 19p13.2 | |
| Cytoband | 7q21.1 | 1.57e-06 | 8 | 141 | 3 | 7q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | MBD3L5 PODNL1 MBD3L2 CC2D1A MBD3L3 MBD3L4 MBD3L2B ADAMTS10 ACTL9 NOTCH3 IL27RA RAVER1 | 7.14e-06 | 797 | 141 | 12 | chr19p13 |
| Cytoband | 10q24 | 1.73e-04 | 35 | 141 | 3 | 10q24 | |
| Cytoband | 18q22.3 | 9.58e-04 | 15 | 141 | 2 | 18q22.3 | |
| GeneFamily | Cytochrome P450 family 3 | 4.77e-06 | 8 | 81 | 3 | 1002 | |
| GeneFamily | Heat shock 70kDa proteins | 5.63e-05 | 17 | 81 | 3 | 583 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.82e-04 | 161 | 81 | 5 | 593 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF142 ZNF843 SALL3 PATZ1 ADNP2 ZNF469 SP6 INSM2 ZFHX3 ZBTB3 | 1.35e-03 | 718 | 81 | 10 | 28 |
| GeneFamily | Immunoglobulin like domain containing | 1.75e-03 | 193 | 81 | 5 | 594 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.00e-03 | 15 | 81 | 2 | 529 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 6.09e-08 | 20 | 141 | 5 | MM1104 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | SZT2 LARP1 SRCAP MSTO1 SCAF1 ZDHHC24 KCNK5 ZC3H7B HCFC1 ABCC10 CAPN15 | 2.31e-06 | 338 | 141 | 11 | M17094 |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP | 1.24e-05 | 198 | 141 | 8 | M3596 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP | 1.28e-05 | 199 | 141 | 8 | M3478 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 1.78e-05 | 10 | 141 | 3 | MM1243 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 3.34e-05 | 166 | 141 | 7 | M7009 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN | 3.61e-05 | 168 | 141 | 7 | M7007 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 2.34e-06 | 188 | 141 | 7 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 4.79e-06 | 136 | 141 | 6 | f024015bf60e64b8657e410e24995a1edec85196 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-05 | 165 | 141 | 6 | 94a5211072464fc24592bb107a853ce832e816fe | |
| ToppCell | facs-GAT-Fat-18m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 168 | 141 | 6 | d6c8056b7d6b937bb91e6b33beeb1075dce1685c | |
| ToppCell | facs-GAT-Fat-18m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 168 | 141 | 6 | 7102c52bf1b2ba67bb3700932181a2e0a6627711 | |
| ToppCell | facs-GAT-Fat-18m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 168 | 141 | 6 | 68a2f9fd53b54023241acd1620cf24226f639c1b | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-05 | 173 | 141 | 6 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | be7c7db6b99603759593e6f79cdcaa4bbf234cb7 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | c37c623c4a5ff1628486d8a6461fa355ad5c264c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 185 | 141 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 2.93e-05 | 187 | 141 | 6 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.02e-05 | 188 | 141 | 6 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-05 | 189 | 141 | 6 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-05 | 193 | 141 | 6 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-05 | 193 | 141 | 6 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-05 | 198 | 141 | 6 | e3e2233c796d5e9051c8c1b66f70f406f048ed56 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-05 | 198 | 141 | 6 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | C_01|World / shred on cell type and cluster | 4.03e-05 | 198 | 141 | 6 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-05 | 198 | 141 | 6 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.03e-05 | 198 | 141 | 6 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-05 | 198 | 141 | 6 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-05 | 198 | 141 | 6 | 2967fb2d94662997bfe932ac299c80d6f182fb48 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-05 | 198 | 141 | 6 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-05 | 199 | 141 | 6 | 043c65bdf54a1bf0e483fea9ffc042ff5b271764 | |
| ToppCell | Caecum-T_cell-Th1|T_cell / Region, Cell class and subclass | 4.14e-05 | 199 | 141 | 6 | 13a80e6d3cf9c831edbe0644545071153e35f82b | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 4.26e-05 | 200 | 141 | 6 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 4.26e-05 | 200 | 141 | 6 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 4.26e-05 | 200 | 141 | 6 | 9769185abae084ffac36420c749625e679b70ca8 | |
| Computational | Cytochrome P450. | 1.12e-04 | 14 | 75 | 3 | MODULE_106 | |
| Drug | desmethyltrimipramine | 4.72e-08 | 7 | 140 | 4 | CID000160632 | |
| Drug | 16-O-demethylaconitine | 4.72e-08 | 7 | 140 | 4 | ctd:C486136 | |
| Drug | Voriconazole | 4.72e-08 | 7 | 140 | 4 | ctd:D065819 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 9.40e-08 | 8 | 140 | 4 | CID006439499 | |
| Drug | 11-HODE | 9.40e-08 | 8 | 140 | 4 | CID006438497 | |
| Drug | 4-hydroxyalprazolam | 9.40e-08 | 8 | 140 | 4 | CID000182017 | |
| Drug | phenylcyclopropane | 1.68e-07 | 9 | 140 | 4 | CID000070112 | |
| Drug | mono-N-demethyladinazolam | 2.28e-07 | 3 | 140 | 3 | ctd:C050132 | |
| Drug | Delavirdine | 2.28e-07 | 3 | 140 | 3 | ctd:D020008 | |
| Drug | Celsior | 2.79e-07 | 10 | 140 | 4 | ctd:C088453 | |
| Drug | 8-hydroxydaidzein | 2.79e-07 | 10 | 140 | 4 | CID005466139 | |
| Drug | AHMA | 2.79e-07 | 10 | 140 | 4 | CID000216240 | |
| Drug | polybrominated biphenyl | 2.83e-07 | 44 | 140 | 6 | CID000042948 | |
| Drug | omeprazole sulfone | 3.17e-07 | 24 | 140 | 5 | CID000145900 | |
| Drug | Haloperidol metabolite I | 4.37e-07 | 11 | 140 | 4 | CID000038282 | |
| Drug | 5-hydroxydiclofenac | 6.52e-07 | 12 | 140 | 4 | CID003052566 | |
| Drug | 2-Tbmbfd | 6.52e-07 | 12 | 140 | 4 | CID000126928 | |
| Drug | 4-(N-propionylanilino)piperidine | 6.52e-07 | 12 | 140 | 4 | CID000259381 | |
| Drug | norclozapine | 6.52e-07 | 12 | 140 | 4 | ctd:C058272 | |
| Drug | 1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea | 9.06e-07 | 4 | 140 | 3 | ctd:C558737 | |
| Drug | hydroxytrimipramine | 9.06e-07 | 4 | 140 | 3 | CID000160610 | |
| Drug | rabeprazole-thioether | 9.06e-07 | 4 | 140 | 3 | ctd:C523099 | |
| Drug | 5-methoxyflavone | 9.06e-07 | 4 | 140 | 3 | CID000094525 | |
| Drug | N-ethyl-3-toluamide | 9.06e-07 | 4 | 140 | 3 | ctd:C454678 | |
| Drug | AC1L18GM | 9.38e-07 | 13 | 140 | 4 | CID000000092 | |
| Drug | 1'-hydroxymidazolam | 9.38e-07 | 13 | 140 | 4 | CID000107917 | |
| Drug | clozapine N-oxide | 9.38e-07 | 13 | 140 | 4 | CID000036727 | |
| Drug | 5-hydroxyomeprazole | 9.38e-07 | 13 | 140 | 4 | CID000119560 | |
| Drug | propionanilide | 1.31e-06 | 14 | 140 | 4 | CID000012107 | |
| Drug | carboxytolbutamide | 1.31e-06 | 14 | 140 | 4 | CID000159651 | |
| Drug | BP-7,8-oxide | 1.44e-06 | 32 | 140 | 5 | CID000037455 | |
| Drug | 2'-(glutathion-S-yl)-deschlorodiclofenac | 1.77e-06 | 15 | 140 | 4 | ctd:C586542 | |
| Drug | 4-hydroxymephenytoin | 1.77e-06 | 15 | 140 | 4 | CID000119507 | |
| Drug | N-desethyloxybutynin | 1.77e-06 | 15 | 140 | 4 | CID000133577 | |
| Drug | 2-oxo-clopidogrel | 2.26e-06 | 5 | 140 | 3 | ctd:C540904 | |
| Drug | benfuracarb | 2.26e-06 | 5 | 140 | 3 | ctd:C096128 | |
| Drug | mono(2-ethyl-5-hydroxyhexyl) phthalate | 2.26e-06 | 5 | 140 | 3 | ctd:C479069 | |
| Drug | pantoprazole | 2.29e-06 | 35 | 140 | 5 | CID000004679 | |
| Drug | AC1L1CJI | 2.29e-06 | 35 | 140 | 5 | CID000001929 | |
| Drug | HCFC-141b | 2.35e-06 | 16 | 140 | 4 | CID000015586 | |
| Drug | 6-hydroxychlorzoxazone | 2.35e-06 | 16 | 140 | 4 | CID000002734 | |
| Drug | desmethylazelastine | 2.35e-06 | 16 | 140 | 4 | CID000162558 | |
| Drug | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | 2.35e-06 | 16 | 140 | 4 | ctd:C495657 | |
| Drug | diosmetin | 3.06e-06 | 17 | 140 | 4 | ctd:C039602 | |
| Drug | piperonyl butoxide | 3.56e-06 | 67 | 140 | 6 | CID000005794 | |
| Drug | menthofuran | 3.92e-06 | 18 | 140 | 4 | CID000329983 | |
| Drug | Azamulinum | 3.92e-06 | 18 | 140 | 4 | CID003086060 | |
| Drug | 7-benzyloxyquinoline | 3.92e-06 | 18 | 140 | 4 | CID003035604 | |
| Drug | hydrocotarnine | 4.49e-06 | 6 | 140 | 3 | CID000003646 | |
| Drug | 4'-methoxyflavone | 4.49e-06 | 6 | 140 | 3 | CID000077793 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 4.49e-06 | 6 | 140 | 3 | ctd:C570106 | |
| Drug | droloxifene | 4.49e-06 | 6 | 140 | 3 | ctd:C038345 | |
| Drug | avasimibe | 4.49e-06 | 6 | 140 | 3 | ctd:C423185 | |
| Drug | mono(2-ethyl-5-oxohexyl)phthalate | 4.49e-06 | 6 | 140 | 3 | ctd:C080276 | |
| Drug | AC1O5Z5L | 4.49e-06 | 6 | 140 | 3 | CID006443527 | |
| Drug | Cyclodextrins | 4.49e-06 | 6 | 140 | 3 | ctd:D003505 | |
| Drug | mepirodipine | 4.49e-06 | 6 | 140 | 3 | ctd:C050699 | |
| Drug | hydroxytolbutamide | 4.94e-06 | 19 | 140 | 4 | CID000003656 | |
| Drug | 6|A-Hydroxycortisol | 4.94e-06 | 19 | 140 | 4 | CID000150985 | |
| Drug | rabeprazole | 4.94e-06 | 19 | 140 | 4 | CID000005029 | |
| Drug | diethylnitrosamine | 5.70e-06 | 111 | 140 | 7 | CID000005921 | |
| Drug | N'-nitrosoanatabine | 6.15e-06 | 20 | 140 | 4 | CID000051291 | |
| Drug | NSC76436 | 6.15e-06 | 20 | 140 | 4 | CID000002828 | |
| Drug | 3C etc | 6.15e-06 | 20 | 140 | 4 | CID000164045 | |
| Drug | 3-methoxymorphinan | 6.15e-06 | 20 | 140 | 4 | CID000001671 | |
| Drug | N-benzylformamide | 7.45e-06 | 76 | 140 | 6 | CID000080654 | |
| Drug | AC1L21VM | 7.56e-06 | 21 | 140 | 4 | CID000039524 | |
| Drug | nirvanol | 7.56e-06 | 21 | 140 | 4 | CID000091480 | |
| Drug | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | 7.82e-06 | 7 | 140 | 3 | ctd:C547858 | |
| Drug | 4-(4-chlorobenzyl)pyridine | 7.82e-06 | 7 | 140 | 3 | CID000078124 | |
| Drug | 5-hydroxydiclofenac | 7.82e-06 | 7 | 140 | 3 | ctd:C117715 | |
| Drug | norfluoxetine | 7.82e-06 | 7 | 140 | 3 | ctd:C036139 | |
| Drug | quinidine-N-oxide | 7.82e-06 | 7 | 140 | 3 | CID000050979 | |
| Drug | 12-hydroxyellipticine | 7.82e-06 | 7 | 140 | 3 | ctd:C517214 | |
| Drug | 6-Fluoro-6-desoxyoxymorphone | 7.82e-06 | 7 | 140 | 3 | CID005486899 | |
| Drug | N'-nitrosoanabasine | 9.19e-06 | 22 | 140 | 4 | CID000014335 | |
| Drug | perazine | 1.11e-05 | 23 | 140 | 4 | CID000004744 | |
| Drug | YM-09730-5 | 1.11e-05 | 23 | 140 | 4 | CID000002296 | |
| Drug | 3'-amino-3'-deoxythymidine | 1.11e-05 | 23 | 140 | 4 | CID000108074 | |
| Drug | HCFC-123 | 1.11e-05 | 23 | 140 | 4 | CID000009385 | |
| Drug | 2cgu | 1.13e-05 | 48 | 140 | 5 | CID003506204 | |
| Drug | nitro-L | 1.13e-05 | 48 | 140 | 5 | CID000006849 | |
| Drug | retrorsine | 1.25e-05 | 8 | 140 | 3 | ctd:C003300 | |
| Drug | nafimidone | 1.25e-05 | 8 | 140 | 3 | CID000051199 | |
| Drug | bifendate | 1.25e-05 | 8 | 140 | 3 | CID000108213 | |
| Drug | AC1L4AGK | 1.25e-05 | 8 | 140 | 3 | CID000182186 | |
| Drug | 11 beta-hydroxytestosterone | 1.25e-05 | 8 | 140 | 3 | CID000114920 | |
| Drug | precocene I | 1.25e-05 | 8 | 140 | 3 | CID000028619 | |
| Drug | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 1.25e-05 | 8 | 140 | 3 | ctd:C585955 | |
| Drug | ABT-761 | 1.25e-05 | 8 | 140 | 3 | CID003086671 | |
| Drug | territrem A | 1.25e-05 | 8 | 140 | 3 | CID000115079 | |
| Drug | desmethylmaprotiline | 1.25e-05 | 8 | 140 | 3 | CID000119409 | |
| Drug | germacrone | 1.25e-05 | 8 | 140 | 3 | ctd:C048393 | |
| Drug | 19-HETE | 1.26e-05 | 49 | 140 | 5 | CID006439528 | |
| Drug | KW-3049 | 1.39e-05 | 50 | 140 | 5 | CID000002324 | |
| Drug | 6-hydroxymelatonin | 1.39e-05 | 50 | 140 | 5 | CID000001864 | |
| Drug | trans-permethrin | 1.52e-05 | 86 | 140 | 6 | CID000040159 | |
| Drug | methylpropylnitrosamine | 1.57e-05 | 25 | 140 | 4 | CID000013545 | |
| Drug | Aconitine | 1.57e-05 | 25 | 140 | 4 | ctd:D000157 | |
| Drug | AC1L44DC | 1.57e-05 | 25 | 140 | 4 | CID000150456 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 8.89e-07 | 5 | 133 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Nodular glomerulosclerosis | 1.13e-06 | 41 | 133 | 5 | C0017667 | |
| Disease | metabolonic lactone sulfate measurement | 1.45e-06 | 19 | 133 | 4 | EFO_0800659 | |
| Disease | Diabetic Nephropathy | 1.63e-06 | 44 | 133 | 5 | C0011881 | |
| Disease | H/O: depression | 2.02e-05 | 2 | 133 | 2 | C0455503 | |
| Disease | Proton pump inhibitor response | 2.02e-05 | 2 | 133 | 2 | cv:CN297082 | |
| Disease | Esomeprazole response | 2.02e-05 | 2 | 133 | 2 | cv:CN077982 | |
| Disease | liver cirrhosis (is_marker_for) | 3.56e-05 | 82 | 133 | 5 | DOID:5082 (is_marker_for) | |
| Disease | X-21258 measurement | 6.03e-05 | 3 | 133 | 2 | EFO_0800802 | |
| Disease | mean arterial pressure | CYP2C19 TBX4 PCNX3 SZT2 ZNF831 TFE3 AGXT ZFHX3 RNF32-DT ABCC10 | 9.24e-05 | 499 | 133 | 10 | EFO_0006340 |
| Disease | coronary artery disease | COL6A3 PCNX3 DOK3 MAGI3 ZNF831 GGCX TGFB1 IGF2R AGXT SP6 KCNK5 BSN ABCC10 MRTFA RAI1 TBCD | 9.81e-05 | 1194 | 133 | 16 | EFO_0001645 |
| Disease | lymphocyte count | CYP2C19 CYP2C9 GBF1 ZAN FRAT1 CYP3A4 CYP3A5 IRF5 ZNF831 ZNF469 TLE4 SP6 ZC3H7B HSPA1A HSPA1B MRTFA RAI1 IL27RA | 1.05e-04 | 1464 | 133 | 18 | EFO_0004587 |
| Disease | tacrolimus measurement | 1.20e-04 | 4 | 133 | 2 | EFO_0008458 | |
| Disease | Clozapine response | 1.20e-04 | 4 | 133 | 2 | cv:CN077971 | |
| Disease | Major Depressive Disorder | 1.22e-04 | 243 | 133 | 7 | C1269683 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.69e-04 | 24 | 133 | 3 | C0887833 | |
| Disease | pulse pressure measurement | COL6A3 CYP2C9 IRF5 SRCAP ZNF831 TGFB1 TGFBR3 KIAA1549L MTF1 ARHGAP12 ZFHX3 SPINDOC HCFC1 MAP4K2 TRAPPC9 ABCC10 NOTCH3 | 1.79e-04 | 1392 | 133 | 17 | EFO_0005763 |
| Disease | Cerebrovascular accident | 1.80e-04 | 62 | 133 | 4 | C0038454 | |
| Disease | Unipolar Depression | 1.80e-04 | 259 | 133 | 7 | C0041696 | |
| Disease | eosinophilic esophagitis (is_implicated_in) | 2.00e-04 | 5 | 133 | 2 | DOID:13922 (is_implicated_in) | |
| Disease | breast carcinoma (is_marker_for) | 2.29e-04 | 66 | 133 | 4 | DOID:3459 (is_marker_for) | |
| Disease | pneumonia (is_marker_for) | 2.70e-04 | 28 | 133 | 3 | DOID:552 (is_marker_for) | |
| Disease | renal cell carcinoma (is_implicated_in) | 2.72e-04 | 69 | 133 | 4 | DOID:4450 (is_implicated_in) | |
| Disease | hair colour measurement | ZNF831 DENND1A MSX2 ZNF469 TLE4 SLC49A4 SP6 SLA2 RNF32-DT TBCD | 4.90e-04 | 615 | 133 | 10 | EFO_0007822 |
| Disease | Drug Allergy | 5.27e-04 | 35 | 133 | 3 | C0013182 | |
| Disease | beta-Ala-His dipeptidase measurement | 5.55e-04 | 8 | 133 | 2 | EFO_0008033 | |
| Disease | Kidney Diseases | 6.86e-04 | 88 | 133 | 4 | C0022658 | |
| Disease | angiotensin-converting enzyme measurement | 7.11e-04 | 9 | 133 | 2 | EFO_0006515 | |
| Disease | mitral valve prolapse (is_implicated_in) | 7.11e-04 | 9 | 133 | 2 | DOID:988 (is_implicated_in) | |
| Disease | familial Mediterranean fever (is_implicated_in) | 7.11e-04 | 9 | 133 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | Major depression, single episode | 7.11e-04 | 9 | 133 | 2 | C0024517 | |
| Disease | Endomyocardial Fibrosis | 7.11e-04 | 9 | 133 | 2 | C0553980 | |
| Disease | Reperfusion Injury | 7.16e-04 | 89 | 133 | 4 | C0035126 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 8.86e-04 | 10 | 133 | 2 | EFO_0022090 | |
| Disease | obstructive jaundice (biomarker_via_orthology) | 8.86e-04 | 10 | 133 | 2 | DOID:13603 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | 9.82e-04 | 447 | 133 | 8 | C3714756 | |
| Disease | Berylliosis | 1.08e-03 | 11 | 133 | 2 | C0005138 | |
| Disease | X-11308 measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0800693 | |
| Disease | Beryllium Disease | 1.08e-03 | 11 | 133 | 2 | C2350873 | |
| Disease | Acute kidney injury | 1.15e-03 | 101 | 133 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 1.15e-03 | 101 | 133 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 1.15e-03 | 101 | 133 | 4 | C0022660 | |
| Disease | pulmonary fibrosis (implicated_via_orthology) | 1.29e-03 | 12 | 133 | 2 | DOID:3770 (implicated_via_orthology) | |
| Disease | metabolite measurement, body weight gain | 1.29e-03 | 12 | 133 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | thymol sulfate measurement | 1.29e-03 | 12 | 133 | 2 | EFO_0021170 | |
| Disease | methionine sulfone measurement | 1.29e-03 | 12 | 133 | 2 | EFO_0800072 | |
| Disease | Kidney Failure, Chronic | 1.34e-03 | 48 | 133 | 3 | C0022661 | |
| Disease | Colorectal Carcinoma | 1.34e-03 | 702 | 133 | 10 | C0009402 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.40e-03 | 181 | 133 | 5 | DOID:684 (is_implicated_in) | |
| Disease | toxic shock syndrome (is_implicated_in) | 1.52e-03 | 13 | 133 | 2 | DOID:14115 (is_implicated_in) | |
| Disease | colon carcinoma (is_marker_for) | 1.52e-03 | 13 | 133 | 2 | DOID:1520 (is_marker_for) | |
| Disease | Skin Abnormalities | 1.52e-03 | 13 | 133 | 2 | C0037268 | |
| Disease | urinary nitrogen measurement | 1.77e-03 | 14 | 133 | 2 | EFO_0005190 | |
| Disease | systemic scleroderma (is_marker_for) | 1.78e-03 | 53 | 133 | 3 | DOID:418 (is_marker_for) | |
| Disease | Acute Cerebrovascular Accidents | 1.88e-03 | 54 | 133 | 3 | C0751956 | |
| Disease | Carcinoma, Granular Cell | 1.91e-03 | 116 | 133 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.91e-03 | 116 | 133 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.91e-03 | 116 | 133 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.91e-03 | 116 | 133 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.91e-03 | 116 | 133 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 1.91e-03 | 116 | 133 | 4 | C0001418 | |
| Disease | Prostatic Neoplasms | 1.96e-03 | 616 | 133 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.96e-03 | 616 | 133 | 9 | C0376358 | |
| Disease | BMI-adjusted leptin measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0007793 | |
| Disease | body weights and measures, body height | 2.04e-03 | 15 | 133 | 2 | EFO_0004324, EFO_0004339 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0800301 | |
| Disease | glycoprotein measurement | 2.10e-03 | 119 | 133 | 4 | EFO_0004555 | |
| Disease | hypertension (is_implicated_in) | 2.23e-03 | 121 | 133 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 2.32e-03 | 16 | 133 | 2 | EFO_0800305 | |
| Disease | multiple myeloma (is_implicated_in) | 2.42e-03 | 59 | 133 | 3 | DOID:9538 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.47e-03 | 206 | 133 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | Uremia | 2.62e-03 | 17 | 133 | 2 | C0041948 | |
| Disease | hypertension | 2.75e-03 | 307 | 133 | 6 | EFO_0000537 | |
| Disease | hair color | 2.93e-03 | 311 | 133 | 6 | EFO_0003924 | |
| Disease | obesity (implicated_via_orthology) | 2.96e-03 | 215 | 133 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Global developmental delay | 3.14e-03 | 133 | 133 | 4 | C0557874 | |
| Disease | emphysema pattern measurement | 3.28e-03 | 19 | 133 | 2 | EFO_0005850 | |
| Disease | systemic lupus erythematosus | COL6A3 PCNX3 MAGI3 IRF5 SRCAP ZNF831 MTF1 HSPA1A HSPA1B CCDC136 | 3.41e-03 | 799 | 133 | 10 | MONDO_0007915 |
| Disease | serum metabolite measurement | CYP2C9 CYP3A4 CYP3A5 CYP3A43 ACE IGF2R GSE1 CNDP2 ZFHX3 MAP4K2 HSPA8 | 3.74e-03 | 945 | 133 | 11 | EFO_0005653 |
| Disease | stomach cancer (is_implicated_in) | 4.26e-03 | 72 | 133 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | triacylglycerol 58:9 measurement | 4.39e-03 | 22 | 133 | 2 | EFO_0010443 | |
| Disease | impotence (biomarker_via_orthology) | 4.39e-03 | 22 | 133 | 2 | DOID:1875 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGLAGEQPLQAPLLP | 76 | Q6ZRM9 | |
| PVPGQALLDLVVSPP | 351 | P24298 | |
| LLPPQPALALDPGLQ | 21 | P12821 | |
| PPEPGLLPNGTVTLL | 76 | Q96PE1 | |
| LGIPGPTPLPLLGNV | 36 | P20815 | |
| LIVEPPLPQEKAGGP | 156 | Q14687 | |
| LFNPPEVPGLSPVGL | 301 | Q8TC94 | |
| DLLNLDLGPPVSGPP | 631 | Q10567 | |
| LLEGLPGTPQPHRLP | 756 | Q9H324 | |
| LPLTQPVGPINRPVG | 401 | Q6IQ32 | |
| PLLIPAPAPGLTVQL | 11 | Q16790 | |
| LLVEGSFLGDPPIPP | 136 | Q8NI28 | |
| TLPGGSILQPRPSLP | 1651 | Q7Z5J4 | |
| EALGLGPPAAQLTPP | 451 | Q8IY67 | |
| LLAQGLRPESPPPAG | 656 | Q96TA1 | |
| PDILIPPEGIPGSAQ | 691 | Q12851 | |
| PVLNGVLPKPPAILG | 81 | O75808 | |
| NGIESLGVKPDLPPP | 1786 | P51610 | |
| LLDLLPVALPPGAGP | 81 | Q5T3U5 | |
| GLPIQVPDRVPPGTL | 1221 | Q96JQ0 | |
| PRPLQLPGAEGPAIS | 76 | Q6PKG0 | |
| PLAPGEPEGPSLLVA | 586 | Q96DN6 | |
| GALPSLLQPPGPLLS | 756 | Q96DN6 | |
| GALLLPLVLPGDPPA | 211 | Q8NCK7 | |
| PGSPFPPEGLDLVIQ | 996 | Q14667 | |
| PPLPPGGQELLELLL | 126 | Q9Y4H4 | |
| ADVPLLILRGGPPSP | 646 | Q5TCQ9 | |
| TLPGLMPLPAGLPNL | 301 | Q9H8Y8 | |
| GPLAPGPHQVPLDLV | 36 | Q9UHF5 | |
| TPGLLPQDLPPSVLA | 231 | P0C025 | |
| VALKVLVPPNIEPGP | 1886 | Q8NDA2 | |
| PLGIAGQPILPDFDP | 51 | Q16206 | |
| GFQPLLNGSLVPVPP | 711 | B1AK53 | |
| SPYLPGIQIVTPGPL | 2741 | Q9UPA5 | |
| LGIPGPTPLPFLGNI | 36 | P08684 | |
| AEGVPGQLPPGLLLL | 401 | O14498 | |
| LPPPLSGQLVTPADI | 161 | A6NJ08 | |
| LSGIPPAPRGVPQIE | 461 | P0DMV9 | |
| KLIGDLPQTPPGAVP | 191 | Q9H6A9 | |
| GGGLPALPPSLVPLV | 331 | O95279 | |
| GAIIPFPLAPGQSLP | 371 | Q9BUK6 | |
| LPPPLSGQLVTPADI | 161 | A0A1B0GVZ6 | |
| LLPLAPGPQLLNPGT | 2186 | Q9UM47 | |
| PVLPPVAVLPLGTGN | 451 | P23743 | |
| PEELGLLGPPRPQVL | 621 | Q6UWB1 | |
| GPQSLPLLLGPEPND | 361 | Q7L591 | |
| PGLLTPQPLKPLAVG | 861 | Q96RT7 | |
| PPALGSLLQLPDGSP | 61 | Q6ZVL6 | |
| PTLPSPPAEAGLGLE | 566 | Q8IXW0 | |
| PLVVLGLPAPTAPSG | 171 | Q8N159 | |
| GPLPASLPPAGEQLL | 221 | Q13568 | |
| GLQVLTHPEPPLPQG | 386 | Q96T92 | |
| DSPLLGPPVGEPRLL | 151 | Q9NYZ3 | |
| LPPPLSGQLVTPADI | 161 | A6NE82 | |
| PLQGPGLLSVPNLPE | 66 | O75694 | |
| LPPLPGSPAIQINGE | 256 | Q8IWW6 | |
| TPAPGLLKVPVPGLG | 296 | P0CG20 | |
| LPPPRLGENGLPISE | 326 | Q9HBE1 | |
| LLLPGPPPVAGLEDA | 16 | Q6PEZ8 | |
| PGPTPLPVIGNILQI | 31 | P33261 | |
| LGIPGPTPLPFLGTI | 36 | Q9HB55 | |
| EGLRGLVTTAPLPPP | 456 | Q9P218 | |
| GPLVVPAPNGTSPLL | 201 | Q96SL1 | |
| PASLPPGDPQLIALI | 41 | Q96IK1 | |
| LQPVLQPLPSPGVGG | 1216 | P12111 | |
| NLPTPPGLSPGDLDV | 666 | Q6P1N0 | |
| GLLPGVVPQGPTELL | 751 | Q8TEH3 | |
| PTELLQPLSPGPGAA | 761 | Q8TEH3 | |
| GPQAGLPPTLLSPVA | 426 | Q9NYP3 | |
| VPLLLPPALAETVGP | 91 | Q92837 | |
| GLHIPPNLSLPVPGA | 296 | P05111 | |
| PPLILQPLASPLQVG | 1806 | Q92538 | |
| PPDDPVILGGPVISL | 146 | Q8IZU9 | |
| LSGIPPAPRGVPQIE | 461 | P0DMV8 | |
| PGPTPLPVIGNILQI | 31 | P11712 | |
| IPLIPPQAQELGIPL | 1481 | A6NE01 | |
| LIPPQAQELGIPLTP | 1531 | A6NE01 | |
| LLPPLLLLAGAVPPG | 21 | Q9NQ36 | |
| VGGPADPIAPTIIIP | 206 | Q58EX2 | |
| LLGAAPGLPSPLLPQ | 351 | Q9BXA9 | |
| LPPQTLEGLQPTGPE | 296 | Q3KP66 | |
| LIDPSSGLPNRLPPG | 221 | Q92530 | |
| LPPPLSGQLVTPADI | 161 | A6NDZ8 | |
| LSSGQLPPLLIPTDP | 956 | Q13029 | |
| LSPFVPGPGPLQTDL | 81 | Q3SYA9 | |
| LTGIPPAPRGVPQIE | 461 | P11142 | |
| LLGVPGGPRPQLQLP | 96 | C9JVW0 | |
| LPPPLSGQLVTPADI | 161 | Q8NHZ7 | |
| VLPIPPVGLYATPVG | 246 | P35548 | |
| GELPELLPPIHPGLL | 386 | A6ND36 | |
| PLLVTAGAPPGGPLV | 91 | Q5VT03 | |
| LLQVPPSGLQGLPPV | 956 | Q2WGJ9 | |
| PIDIGRVAGPPILNP | 1721 | P11717 | |
| LTLEPPGPLPLVSGR | 766 | Q5T011 | |
| PLPTVPGGLSPVQRE | 461 | Q9NUJ3 | |
| KPLSIPNQLLLGPGP | 16 | P21549 | |
| NPILASPPTLGLLEP | 401 | Q9UHX1 | |
| AGPLPGKDIPLPVTV | 196 | Q9H6Q3 | |
| STPLPPREGQGPLEI | 376 | Q6IEE7 | |
| LVLQPGLSEPPQPLL | 421 | Q14872 | |
| PPGGPVPLSVLILSL | 646 | O94933 | |
| PPPLTLAQKLGLIGP | 86 | Q9H0A6 | |
| PEPPLGLLDGLIPLA | 566 | Q2M3G4 | |
| PAPPPGLRGTLDLQV | 311 | Q9BUA3 | |
| PLQPGELQSLPLGPE | 46 | Q3SY56 | |
| QELLGALEPLPPAPG | 881 | Q9ULL5 | |
| PGGLELTPPVVSLTP | 3101 | Q6ZRS2 | |
| LELTLGVTPEGNPPP | 196 | Q9NPQ8 | |
| PAPQLLLGPQGPSLI | 636 | Q969V6 | |
| PEPLPTPHVLLQGLG | 501 | Q6ZMH5 | |
| GPLLLQLGTEPPAPH | 1456 | Q9Y566 | |
| PNPPIFSLPLVGLVV | 1126 | Q96JN2 | |
| QLPDGQSLPIPPVIL | 101 | Q96KN2 | |
| PLPPILLGRLGSDPQ | 76 | Q96KP4 | |
| TGPLPPELQPLLEGE | 631 | P38435 | |
| IHGLPVPPTPGLLSL | 436 | P19532 | |
| PGGGLLPTPNPLTQI | 136 | Q05519 | |
| QPPAIPPIGSSAGLL | 156 | Q04727 | |
| VVTAGGAALPPPLLP | 371 | Q9H7N4 | |
| PLPNLPVGPGDTISI | 706 | Q5VZP5 | |
| GEVPPGPLPEAVLAL | 66 | P01137 | |
| VELEALLPPPGAVPG | 136 | Q6ZSY5 | |
| QPEGGLPVSPEPSLL | 396 | O95359 | |
| EGDIIPPLTGATPPL | 911 | Q12888 | |
| LELAYVLVLGPGPPP | 31 | Q6UX98 | |
| PGSPGPLLQQALPLG | 3556 | Q96JG9 | |
| PLSLQPLVPSGLPAV | 226 | Q8N446 | |
| PGPGPLNVGLHLNPL | 191 | Q8N831 | |
| VPPVSGPLALPALGK | 621 | Q8N1G0 | |
| DLLGVPRPQLVPQPG | 1176 | Q9BTW9 | |
| IALPGGLTLPPVPFT | 521 | Q96Q05 | |
| LGPQPLPIHVGELPT | 586 | P35968 | |
| IAGVSGVDDLPPPPL | 401 | P57082 | |
| LIPPPLSNRGILGPV | 26 | P52746 | |
| TALELPGLPLSLPQP | 91 | Q9H4A3 | |
| LPPTNLPLGTVALPV | 1711 | Q9H4A3 | |
| TLGPVLLPPEQGLAP | 36 | Q5JPB2 | |
| LDPFGTGQPLPPLQI | 356 | O94979 | |
| LLGQDVFLIGPPGPL | 101 | A3KMH1 | |
| EITNGPLISLLPKPP | 376 | A6NCI4 | |
| ILLDPGALPALQNPP | 376 | Q03167 | |
| PALQGIPPVLLPGLN | 3116 | Q15911 | |
| SELPQLIPVFPGGTP | 286 | Q9UGR2 | |
| ELLLGSPAGSPPIPL | 466 | Q9Y493 | |
| EVGPLLGVQPLPGSP | 536 | Q9H5J0 | |
| LPLQDTGPTSGPEPL | 926 | O15069 | |
| NIAGDSLGLALPPPP | 281 | Q96PU5 |